4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000148
Chairperson & CEO sold 9,500 shares at an average $491.57 ($4,669,918)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
13 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-23 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-09-23 | Sale : show line 2 in the form 10b5-1 | −2,388 | $488.70 | $1,167,007 | 331,555 | I |
| 2026-09-23 | Sale : show line 3 in the form 10b5-1 | −2,162 | $489.52 | $1,058,351 | 329,393 | I |
| 2026-09-23 | Sale : show line 4 in the form 10b5-1 | −1,440 | $490.48 | $706,286 | 327,953 | I |
| 2026-09-23 | Sale : show line 5 in the form 10b5-1 | −824 | $491.65 | $405,124 | 327,129 | I |
| 2026-09-23 | Sale : show line 6 in the form 10b5-1 | −480 | $492.54 | $236,421 | 326,649 | I |
| 2026-09-23 | Sale : show line 7 in the form 10b5-1 | −160 | $493.72 | $78,996 | 326,489 | I |
| 2026-09-23 | Sale : show line 8 in the form 10b5-1 | −155 | $495.17 | $76,752 | 326,334 | I |
| Open-market sales · 9,500 sh · avg $491.57 · $4,669,918 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-23 | Exercise or conversion : show line 14 in the form 10b5-1 Stock Option | −9,500 | 375,910 | I |
Loading xslF345X06/primarydocument.xml…